Carl Harald Janson, Manager, International Biotechnology Trust
Carl Harald Janson, manager of International Biotechnology Trust, explains the case for investing in biotechnology and healthcare.
Rosemary Banyard, Manager, Schroder UK Mid Cap
Rosemary Banyard, Manager of Schroder UK Mid Cap discusses the outlook for the UK All Companies sector with PR Manager Jemma Jackson.
Guy Anderson, Manager, The Mercantile Investment Trust
Guy Anderson discusses the impact of the election on UK markets with AIC Communications Director Annabel Brodie-Smith.
Company case study: Kidspace, backed by Downing VCTs
Richard Farley, CEO and Founder of Kidspace Adventures, and Mark Gross, Investment Director of Downing discuss the impact of Downing VCTs’ investment.
AIC panel discussion: Alternative income
AIC Communications Director Annabel Brodie-Smith is joined by Kenneth MacKenzie, Manager of Target Healthcare REIT, and Stephen Ellis, Manager of GCP Infrastructure, to discuss the income advantages of alternative assets.
Company case study: CREATE Fertility, backed by Baronsmead VCTs, Livingbridge
Praful Nargund, Director of Strategy at CREATE Fertility and Benoit Broch, Director, Investment Team at Livingbridge, explain how VCTs have supported CREATE Fertility.
Tim Levett, Chairman, NVM on the outlook for VCTs
Tim Levett, Chairman, NVM looks at the role of VCTs and their performance.
Company case study: DySIS, backed by Albion VCTs
Andrew Elder, Partner, Albion Ventures LLP explains the impact of Albion VCTs’ support of DySIS
Company case study: Mirriad, backed by Edge VCTs
Mark Popkiewicz, CEO of Mirriad, David Glick, Founder & CEO of Edge Group explain the impact of VCT support for Mirriad and British companies.